Aligos Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-16. The offering totals $125.0M, of which $85.0M was reported sold. Industry: Biotechnology.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| Kathleen Glaub | Director | San Diego, CA |
| Peter Hirth | Director | South San Francisco, CA |
| Peter Moldt | Director | Seattle, WA |
| Carole Neuchterlein | Director | South San Francisco, CA |
| Jack Nielsen | Director | Palo Alto, CA |
| Tom Woiwode | Director | Del Mar, CA |
| Michael Yi | Director | South San Francisco, CA |
| Sushmita Chanda | Executive Officer | South San Francisco, CA |
| Brian Dowd | Executive Officer | South San Francisco, CA |
| John Fry | Executive Officer | London, X0 |
| Lucinda Quan | Executive Officer | South San Francisco, CA |
| Julian Symons | Executive Officer | South San Francisco, CA |
| Lesley Ann Calhoun | Executive Officer | Boston, MA |
| Bridget Peter Martell | Director | South San Francisco, CA |
| Julian Peter Symons | Executive Officer | South San Francisco, CA |
| Margarita Peter Chavez | Director | South San Francisco, CA |
| K. Peter Hirth | Director | South San Francisco, CA |
| Heather Peter Preston | Director | South San Francisco, CA |
| Lawrence M Blatt | Director | South San Francisco, CA |
| Lawrence M Blatt | Executive Officer | South San Francisco, CA |
| James Peter Scopa | Director | South San Francisco, CA |
| Hardean Peter Achneck | Executive Officer | South San Francisco, CA |
| Carole Peter Nuechterlein | Director | South San Francisco, CA |
| Bridget Ann Martell | Director | South San Francisco, CA |
| Jack Ann Nielsen | Director | South San Francisco, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-02-28 | D | $105.0M | $105.0M |
| 2023-11-07 | D | $92.2M | $92.2M |